1nHealth
Technology/Service ProviderIf you’ve ever lost sleep over delayed study enrollment, consider 1nHealth your new weighted blanket. 1nHealth fills studies through a simple philosophy: Don’t waste the power of…
Taimei Technology offers market-leading digital intelligence solutions that are transforming the life sciences industry, with a particular focus on pharmaceutical R&D, pharmacovigilance, and marketing. Our flagship platforms include: Trials Clinical Research Collaboration Platform A cutting-edge platform that facilitates seamless collaboration among pharmaceutical companies, hospitals, CROs, SMOs, and regulatory bodies. The platform enhances clinical research efficiency by leveraging AI, big data, and cloud computing to streamline processes, ensure data standardization, and integrate resources. Boundless Academic Exchange Platform A pioneering platform designed to connect stakeholders within the life sciences industry, fostering academic collaboration and knowledge exchange. This solution supports the sharing of insights and best practices across various entities, including pharmaceutical companies, healthcare institutions, and regulatory agencies. These products lead the market in Asia-Pacific and have a strong presence in North America, and Europe. By providing digital solutions to over 1,200 pharmaceutical companies, 250 CROs, and 700 hospitals, Taimei Technology continues to drive digital transformation, significantly improving drug R&D efficiency, post-market performance, delivering value and fostering beneficial outcomes for all stakeholders.
If you’ve ever lost sleep over delayed study enrollment, consider 1nHealth your new weighted blanket. 1nHealth fills studies through a simple philosophy: Don’t waste the power of…
Leveraging over 30 years of experience working with large biopharma, emerging biotech, CROs, and healthcare companies, the strategic advisors, executives, and subject matter…
Block Clinical is intently focused on streamlining the myriad of logistics involved in traditional, virtual, and hybrid clinical trials. From globally integrated patient…